Study Details
Efficacy and Safety of IMAB362 in Combination With the EOX Regimen for CLDN18.2-positive Gastric Cancer
Clinicaltrials.gov ID
Astellas Study ID
GM-IMAB-001-03
EudraCT ID
2011-005285-38
Condition
Stomach or Esophageal Cancer
Phase
Phase 2
Age
18 years - N/A
Sex
Female & Male
Product
N/A
Type
Interventional
Trial Dates
Jul 2012 - Jan 2019
Masking
Not Available
Enrollment number
252
A Randomized Phase II Multicenter, Open-Label Study Evaluating the Efficacy and Safety of IMAB362 in Combination with the EOX (Epirubicin, Oxaliplatin, Capecitabine) Regimen as First-Line Treatment of Patients with CLDN18.2-Positive Advanced Adenocarcinomas of the Stomach, the Esophagus or the Gastroesophageal Junction
Study summary
Get More Information
Would you like more information about clinical trial sites that are recruiting participants for Efficacy and Safety of IMAB362 in Combination With the EOX Regimen for CLDN18.2-positive Gastric Cancer? Contact us by filling our your information to the right and we’ll respond to you.
Locations
Site UKR015
Poltava, Ukraine
Site GER010
Dresden, Germany
Site RUS005
Pyatigorsk, Russian Federation
Site GER019
Freiburg, Germany
Site GER011
Lebach, Germany
Site RUS001
Moscow, Russian Federation
Site BUL002
Varna, Bulgaria
Site RUS019
Ryazan, Russian Federation
Site RUS012
Orel, Russian Federation
Site UKR001
Donetsk, Ukraine
Site GER013
Pinneberg, Germany
Site RUS014
Orenburg, Russian Federation
Site LAT003
Daugavpils, Latvia
Site RUS013
Yaroslavl, Russian Federation
Site GER017
Frankfurt, Germany
Site UKR009
Zaporizhia, Ukraine
Site BUL004
Plovdiv, Bulgaria
Site UKR010
Uzhhorod, Ukraine
Site GER029-01
Bochum, Germany
Site UKR006
Lviv, Ukraine
Site LAT002
Riga, Latvia
Site UKR002
Donetsk, Ukraine
Site BUL001
Sofia, Bulgaria
Site GER001
Essen, Germany
Site BUL003
Sofia, Bulgaria
Site GER020
Leipzig, Germany
Site RUS007
Ivanovo, Russian Federation
Site CZE002
Olomouc, Czech Republic
Site RUS016
Bryansk, Russian Federation
Site CZE003
Prague, Czech Republic
Site RUS004
Ekaterinburg, Russian Federation
Site UKR007
Kyiv, Ukraine
Site BUL005
Sofia, Bulgaria
Site RUS002
Obninsk, Russian Federation
Site RUS003
St.Petersburg, Russian Federation
Site RUS017
Novgorod, Russian Federation
Site GER029
Bochum, Germany
Site CZE001
Znojmo, Czech Republic
Site RUS025
St. Petersburg, Russian Federation
Site RUS006
Chelyabinsk, Russian Federation
Site GER016
Münster, Germany
Site GER012
Bielefeld, Germany
Site UKR005
Kharkiv, Ukraine
Site RUS010
St.Petersburg, Russian Federation
Site RUS015
St.Petersburg, Russian Federation
Site GER018
Stade, Germany
Site RUS011
Arkhangelsk, Russian Federation
Site RUS023
Omsk, Russian Federation
Site RUS009
Kursk, Russian Federation
Site GER005
Halle/Saale, Germany
Site UKR004
Simferopol, Ukraine
Site UKR011
Sumy, Ukraine
Site LAT001
Liepaja, Latvia
Site UKR008
Ivano-Frankivsk, Ukraine
Site UKR003
Dnipropetrovsk, Ukraine